| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $55 | — | — |
| Cost of Revenue | $464 | — | — |
| Gross Profit | -$409 | — | — |
| R&D Expense | $457 | -41.2% | -92.5% |
| SG&A Expense | $713K | +14.2% | +528.2% |
| Interest Expense | $80K | — | — |
| Pre-tax Income | $2.5M | +249.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $9.7M | +422.3% | — |
| Total Assets | $18.2M | +707.9% | — |
| Current Liabilities | $1.6M | +18.9% | — |
| Total Liabilities | $1.6M | +18.9% | — |
| Stockholders' Equity | $16.6M | +1743.1% | +302.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.2M | -5.1% | — |
| Investing Cash Flow | -$4.0M | +18.6% | — |
| Financing Cash Flow | $17.8M | +42.8% | — |
| +351.5% |
| Net Income | $2.5M | +249.0% | +351.5% |
| EPS (Basic) | $0.23 | +243.8% | +227.8% |
| EPS (Diluted) | $0.10 | +162.5% | +155.6% |